These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21632271)

  • 1. Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.
    Mata IF; Wilhoite GJ; Yearout D; Bacon JA; Cornejo-Olivas M; Mazzetti P; Marca V; Ortega O; Acosta O; Cosentino C; Torres L; Medina AC; Perez-Pastene C; Díaz-Grez F; Vilariño-Güell C; Venegas P; Miranda M; Trujillo-Godoy O; Layson L; Avello R; Dieguez E; Raggio V; Micheli F; Perandones C; Alvarez V; Segura-Aguilar J; Farrer MJ; Zabetian CP; Ross OA
    Parkinsonism Relat Disord; 2011 Sep; 17(8):629-31. PubMed ID: 21632271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable frequency of
    Cornejo-Olivas M; Torres L; Velit-Salazar MR; Inca-Martinez M; Mazzetti P; Cosentino C; Micheli F; Perandones C; Dieguez E; Raggio V; Tumas V; Borges V; Ferraz HB; Rieder CRM; Shumacher-Schuh A; Velez-Pardo C; Jimenez-Del-Rio M; Lopera F; Chang-Castello J; Andreé-Munoz B; Waldherr S; Yearout D; Zabetian CP; Mata IF
    NPJ Parkinsons Dis; 2017; 3():19. PubMed ID: 28649619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
    Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
    Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay.
    Mata IF; Cosentino C; Marca V; Torres L; Mazzetti P; Ortega O; Raggio V; Aljanati R; Buzó R; Yearout D; Dieguez E; Zabetian CP
    Parkinsonism Relat Disord; 2009 Jun; 15(5):370-3. PubMed ID: 18980856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease.
    Toft M; Mata IF; Ross OA; Kachergus J; Hulihan MM; Haugarvoll K; Stone JT; Blazquez M; Gibson JM; Aasly JO; White LR; Lynch T; Adler CH; Gwinn-Hardy K; Farrer MJ
    Mov Disord; 2007 Feb; 22(3):389-92. PubMed ID: 17216639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation.
    Nichols WC; Marek DK; Pauciulo MW; Pankratz N; Halter CA; Rudolph A; Shults CW; Wojcieszek J; Foroud T;
    Mov Disord; 2007 Jan; 22(2):254-7. PubMed ID: 17149721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.
    Sadhukhan T; Vishal M; Das G; Sharma A; Mukhopadhyay A; Das SK; Ray K; Ray J
    Dis Markers; 2012; 32(6):355-62. PubMed ID: 22684232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.
    Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME
    Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.
    Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS
    J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.
    Di Fonzo A; Wu-Chou YH; Lu CS; van Doeselaar M; Simons EJ; Rohé CF; Chang HC; Chen RS; Weng YH; Vanacore N; Breedveld GJ; Oostra BA; Bonifati V
    Neurogenetics; 2006 Jul; 7(3):133-8. PubMed ID: 16633828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 variation and Parkinson's disease in African Americans.
    Ross OA; Wilhoite GJ; Bacon JA; Soto-Ortolaza A; Kachergus J; Cobb SA; Puschmann A; Vilariño-Güell C; Farrer MJ; Graff-Radford N; Meschia JF; Wszolek ZK
    Mov Disord; 2010 Sep; 25(12):1973-6. PubMed ID: 20669299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.
    Li C; Ting Z; Qin X; Ying W; Li B; Guo Qiang L; Jian Fang M; Jing Z; Jian Qing D; Sheng Di C
    Mov Disord; 2007 Dec; 22(16):2439-43. PubMed ID: 17960808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
    Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A
    Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi-center pooled analysis.
    Tan EK; Peng R; Wu YR; Wu RM; Wu-Chou YH; Tan LC; An XK; Chen CM; Fook-Chong S; Lu CS
    Am J Med Genet B Neuropsychiatr Genet; 2009 Oct; 150B(7):1022-3. PubMed ID: 19152345
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
    Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
    Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
    Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J
    J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 R1441G in Spanish patients with Parkinson's disease.
    Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
    Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.